echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > [One table summary] "Thyroid nodule" malignant risk and clinical treatment opinions (2017TBSRTC) | Knowledge Card

    [One table summary] "Thyroid nodule" malignant risk and clinical treatment opinions (2017TBSRTC) | Knowledge Card

    • Last Update: 2021-04-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Edited by Yimaitong, please do not reprint without authorization.

    Introduction: Yimaitong Endocrinology Department launched the "Knowledge Card" column, aiming to organize some clinical disease-related knowledge points in a simple and easy-to-save chart form, so that clinicians can use the fragmentary time to review the story.
    In order to help clinicians.

    Fine needle aspiration cytology (FNAC) examination is the most accurate and cost-effective diagnostic method for thyroid nodule evaluation before surgery.

    A number of studies have shown that on the basis of ultrasound evaluation, FNAC for thyroid nodules that meet the indications can effectively improve the diagnosis rate and reduce unnecessary operations for benign lesions.

    Thyroid Cytopathology Bethesda Reporting System (TBSRTC) is currently the most widely accepted thyroid cytology reporting system, which establishes and provides a unified thyroid cytology diagnostic term and criteria.

    The first edition was proposed in 2007 and has since been recommended many times by relevant guidelines of the American Thyroid Association.

    In 2017, the latest version of TBSRTC was released.

     The following table summarizes the 2017 version of TBSRTC's description of the malignant risk assessment of thyroid cells and the description of common clinical treatment opinions.
    Table 1 Thyroid cytopathology Bethesda reporting system: corresponding malignant risk and common clinical treatment Note: a, "suspected malignant" or "malignant" If it is suggested that it is metastatic cancer rather than primary thyroid cancer, it should be treated according to the situation, and surgery is not necessary; NIFTP: Non-invasive thyroid follicular tumor with papillary nucleus characteristics Reference materials: Zhou Yifan, Wang Jianhua, Xu Shuhang .
    Update and research progress of Bethesda reporting system for thyroid cytopathology[J].
    International Journal of Endocrinology and Metabolism.
    Volume 40, Issue 3, May 2020.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.